Clinical Trial

Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

Name: Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP — clinical trial record (NCT07662525)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, open-lable, single-center study and we aimed to determine whether atorvastatin combined with N-acetyl-L-cysteine (NAC) plus romiplostim could induce sustained response off-treatment (SRoT) in adult patients with ITP following CS failure.

Trial Details

NCT Number	NCT07662525
Lead Sponsor	Peking University People's Hospital
Conditions	Immune Thrombocytopenic Purpura
Enrollment	50 participants
Start Date	2026-06-01
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-23